Tag: property portfolio

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required for filing a Biologics License Application (BLA) for Revascor^® (rexlemestrocel-L) in the treatment of patients with ischemic heart failure with reduced ejection fraction (HFrEF) and inflammation.

ORINDA, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) today announced the closing of a $3 million loan agreement with an institutional investor for the purchase of non-traded REIT shares.

The acquisition by Heimar hf. ("Heimar" or the "Company") of all shares in Gróska ehf. (“Gróska”) and Gróðurhúsið ehf. (“Gróðurhúsið”) (the “Transaction”), which was initially announced on 23 April this year, has now been completed. 

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on continued momentum with United States Food and Drug Administration (FDA) regarding both accelerated approval pathway for Revascor^® (rexlemestrocel-L) in the treatment of patients with ischemic chronic heart failure with reduced ejection fraction (HFrEF) and inflammation, and label extension for Ryoncil^® (remestemcel-L-rknd) in adults with steroid refractory acute graft versus host disease (SR-aGvHD).

London, UK, June 09, 2025 (GLOBE NEWSWIRE) -- Binaryx, a fractional real estate investing platform, is announcing its move to commercial scale following a successful pilot phase. With $4.4 million in processed investments, with a second-by-second payment of dividends to investors, and 25 tokenized properties launched, Binaryx is contributing to the broader shift toward real estate tokenization — a market projected to unlock $16 trillion in value by 2030.

Image Description: Sidd Mahajan is the founder and managing director of Tulip Real Estate

New York, NY, June 07, 2025 (GLOBE NEWSWIRE) -- Goldstein Patent Law, a national leader in patent law, is happy to announce it has recently published a new article on How to patent an idea. Leveraging the expertise and nearly 30 years of experience from the founder of the law firm and principal patent attorney Rich Goldstein, the new insights answer the question, “Can a concept be patented?” and help to demystify IP rights, how to secure patent protection and how intellectual property attorneys can help navigate the process.